FDx Advisors’s Integra LifeSciences IART Stock Holding History

FDx Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,586	Closed	-$420K	–	963
2018 Q1	$420K	Sell	7,586 -36	-0.5%	-$1.89K	0.01%	847
2017 Q4	$365K	Sell	7,622 -52	-0.7%	-$2.54K	0.01%	929
2017 Q3	$387K	Sell	7,674 -90	-1%	-$4.62K	0.01%	931
2017 Q2	$423K	Sell	7,764 -171	-2%	-$8.17K	0.01%	833
2017 Q1	$334K	Sell	7,935 -5,287	-40%	-$226K	0.01%	944
2016 Q4	$286K	Buy	13,222 +6,474	+96%	+$263K	0.01%	964
2016 Q3	$279K	Buy	+6,748	New	+$283K	0.01%	796

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FDx Advisors's IART Position: Q2 2018 in Review

FDx Advisors sold out of Integra LifeSciences (IART) in Q2 2018, closing a stake of 7,586 shares — an estimated $420K sold.

FDx Advisors first reported a position in IART in Q3 2016 and held it in 7 quarters. The position peaked at $423K in Q2 2017. 257 funds tracked by Wall St. Rank hold IART as of Q2 2018.

FDx Advisors reported no remaining Integra LifeSciences position as of Q2 2018 after selling out during the quarter.
FDx Advisors sold 7,586 Integra LifeSciences shares in Q2 2018, an estimated $420K.
FDx Advisors first reported a position in Integra LifeSciences in Q3 2016 and held it in 7 quarters.
FDx Advisors's Integra LifeSciences position peaked at $423K in Q2 2017.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2018.

Based on FDx Advisors's 13F filing for Q2 2018, filed 8 Aug 2018.